In AD, DSS intervention is associated with improved cognitive function in patients, as evidenced by clinical evaluations and meta-analyses; this benefit is likely mediated through modulation of brain insulin signaling, neuroinflammation, and Aβ metabolism (Haifang, 2023; Kim and Cho, 2020). The gene discussed is INS; the disease is Alzheimer disease.